Karbassi, Elaheh
Padgett, Ruby
Bertero, Alessandro
Reinecke, Hans
Klaiman, Jordan M.
Yang, Xiulan
Hauschka, Stephen D.
Murry, Charles E. http://orcid.org/0000-0003-3862-6773
Funding for this research was provided by:
NHLBI Division of Intramural Research (F32HL150932, R01HL146868, R01HL148081, R01HL160825, R01HL128368, R01HL141570)
Sponsored Research Agreement, Sana Biotechnology (Sponsored Research Agreement, Sana Biotechnology)
Robert B McMillen Foundation (Robert B McMillen Foundation)
Article History
Received: 8 November 2023
Revised: 11 December 2023
Accepted: 19 December 2023
First Online: 19 February 2024
Declarations
:
: CEM holds equity in Sana Biotechnology and StemCardia. All other authors declare that they have no conflict of interest.
: Not applicable.
: All authors have read and approved the manuscript for publication.
: The WTC11 human induced pluripotent stem cell line was obtained from Dr. Bruce Conklin’s laboratory (Gladstone Institute, UCSF). The WTC11 cells were derived from adult skin fibroblasts, and there is no associated identifier linking the cells to the original donor. The WTC11 cells are also available from Coriell #GM25256 (RRID: CVCL_Y803).